Predictive factors associated with pemetrexed acute toxicity-Reference-Cited by-同舟云学术

Predictive factors associated with pemetrexed acute toxicity

Published:2023-03-23 Issue:5 Volume:79 Page:635-641
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Bonnet Mathilde,Jouinot Anne,Boudou-Rouquette Pascaline,Seif Vanessa,Villeminey Clémentine,Arrondeau Jennifer,Vidal Michel,Batista Rui,Wislez Marie,Blanchet Benoit,Goldwasser François,Thomas-Schoemann Audrey

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-023-03478-4.pdf

Reference22 articles.

1. Gadgeel S, Rodríguez-Abreu D, Speranza G et al (2020) Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer. J Clin Oncol 38:1505–1517. https://doi.org/10.1200/JCO.19.03136

2. ALIMTA: Summary of product characteristics. https://www.ema.europa.eu/en/medicines/human/EPAR/alimta. Accessed 15 Mar 2022

3. Common Terminology Criteria for Adverse Events (CTCAE) v5.0 (2017). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50

4. de Rouw N, Boosman RJ, van de Bruinhorst H et al (2020) Cumulative pemetrexed dose increases the risk of nephrotoxicity. Lung Cancer 146:30–35. https://doi.org/10.1016/j.lungcan.2020.05.022

5. de Rouw N, Piet B, Derijks HJ et al (2021) Mechanisms, management and prevention of pemetrexed-related toxicity. Drug Saf 44(12):1271–1281. https://doi.org/10.1007/s40264-021-01135-2

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy;Drugs - Real World Outcomes;2024-06-19

3. Antineoplastics/cobalamin/folic-acid;Reactions Weekly;2023-09-30

4. Baseline factors associated with pemetrexed-related acute toxicity;Reactions Weekly;2023-04-01